TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

ANDOVER, Mass., Dec. 30, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will present at the upcoming 44^th Annual J.P. Morgan Healthcare Conference. The presentation will take place on Monday, January 12, 2026, at 3:00 pm Pacific Standard Time / 6:00 pm Eastern Standard Time.